Preferred Label : protein-tyrosine kinases;
MeSH definition : Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins
with ATP or other nucleotides as phosphate donors.;
MeSH synonym : kinases, protein-tyrosine; tyrosine kinase; tyrosine protein kinase; kinase, tyrosine protein; tyrosine-specific protein kinase; kinase, tyrosine-specific protein; protein kinase, tyrosine-specific; kinases, tyrosine-specific protein; tyrosine specific protein kinases; tyrosylprotein kinase; protein tyrosine kinase; protein kinases, tyrosine; protein-tyrosine kinase; tyrosine protein kinases; protein kinases, tyrosine-specific; kinase, tyrosylprotein; tyrosine-specific protein kinases; kinase, protein-tyrosine; kinase, tyrosine; kinases, tyrosine protein; tyrosine specific protein kinase; protein tyrosine kinases;
CISMeF synonym : EC 2.7.1.112;
MeSH CAS label : ATP:protein-tyrosine O-phosphotransferase;
MeSH Related Number : EC 2.7.10.2;
Registry Number MeSH : EC 2.7.10.1;
Wikipedia link : https://en.wikipedia.org/wiki/Tyrosine protein kinase;
Is substance : O;
UNII : EC 2.7.10.1;
Origin ID : D011505;
UMLS CUI : C0033681;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
False automatic mappings
Indexing information
- AG 127 [MeSH Supplementary Concept]
- AG 183 [MeSH Supplementary Concept]
- AG 30 [MeSH Supplementary Concept]
- AG 372 [MeSH Supplementary Concept]
- AG 494 [MeSH Supplementary Concept]
- AG 556 [MeSH Supplementary Concept]
- AG-879 [MeSH Supplementary Concept]
- CH 331 [MeSH Supplementary Concept]
- HAJ11 [MeSH Supplementary Concept]
- KB 23 [MeSH Supplementary Concept]
- LFM A13 [MeSH Supplementary Concept]
- ST 271 [MeSH Supplementary Concept]
- ST 638 [MeSH Supplementary Concept]
- SU 4984 [MeSH Supplementary Concept]
- SU 5402 [MeSH Supplementary Concept]
- SU 5768 [MeSH Supplementary Concept]
- TKM0150 [MeSH Supplementary Concept]
- XR774 [MeSH Supplementary Concept]
- desmal [MeSH Supplementary Concept]
- raytide [MeSH Supplementary Concept]
Manual NTBT mappings (CISMeF)
Record concept(s)
Related MeSH Supplementary Concept(s)
- PTK72 [MeSH Supplementary Concept]
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins
with ATP or other nucleotides as phosphate donors.
https://pharmactuel.com/index.php/pharmactuel/article/view/1265
2019
false
false
false
false
France
comparative effectiveness research
treatment outcome
EGFR Gene Mutation
protein kinase inhibitors
protein-tyrosine kinases
antineoplastic agents
Gefitinib
Afatinib
clinical trials, phase iii as topic
antineoplastic agents
protein kinase inhibitors
lung neoplasms
lung neoplasms
carcinoma, non-small-cell lung
osimertinib
osimertinib
Tyrosine Kinase Inhibitors
critical appraisal or critical reading
carcinoma, non-small-cell lung
piperazines
piperazines
acrylamides
aniline compounds
acrylamides
aniline compounds
---
http://www.sfendocrino.org/_images/mediatheque/articles/pdf/recommandations/2018_Immunotherapies%20/mced_94_bd.pdf
2018
false
false
false
France
French
immunotherapy
antibodies, monoclonal
consensus
continuity of patient care
Tyrosine Kinase Inhibitor
protein-tyrosine kinases
protein kinase inhibitors
TOR Serine-Threonine kinases
adrenal glands
pituitary gland
metabolism
endocrine system diseases
diabetes mellitus
Hypophysitis
hypothyroidism
adrenal insufficiency
Hormone Measurement
hormones
Tyrosine Kinase Inhibitors
---
In : Bulletin du Cancer Volume 103, Issue 2, February 2016, Pages 180–189 - Open
Access
http://www.sciencedirect.com/science/article/pii/S0007455115003689
2016
false
false
false
Netherlands
French
journal article
journal article
nilotinib
nilotinib
nilotinib
nilotinib
protein-tyrosine kinases
protein-tyrosine kinases
leukemia, myeloid, chronic-phase
leukemia, myeloid, chronic-phase
cardiovascular diseases
cardiovascular diseases
risk factors
risk factors
risk assessment
risk assessment
cardiovascular diseases
cardiovascular diseases
practice guideline
practice guideline
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
nilotinib
nilotinib
nilotinib
nilotinib
pyrimidines
pyrimidines
pyrimidines
pyrimidines
---
http://www.sciencedirect.com/science/article/pii/S0007455116000606
10.1016/j.bulcan.2016.02.001
2016
false
false
false
France
French
pregnancy
Tyrosine Kinase Inhibitor
protein kinase inhibitors
protein-tyrosine kinases
journal article
risk assessment
review of literature
fetus
abortion, spontaneous
abnormalities, drug-induced
antineoplastic agents
Tyrosine Kinase Inhibitors
---
Summary Safety Review - Bcr-Abl Tyrosine Kinase Inhibitors - Assessing the Potential
Harm to the Fetus
https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tki-ikt-fra.php
2016
false
false
false
Canada
French
English
pregnancy
fusion proteins, bcr-abl
protein kinase inhibitors
protein-tyrosine kinases
drug evaluation
risk assessment
fetus
contraception
abnormalities, drug-induced
Tyrosine Kinase Inhibitor
abortion, spontaneous
hematologic diseases
antineoplastic agents
administration, oral
pharmacovigilance
Tyrosine Kinase Inhibitors
---
http://www.e-cancer.fr/content/download/126025/1524695/file/Médicaments%20ciblant%20BCR-ABL.pdf
2015
false
false
false
France
French
practice guideline
guidelines for drug use
administration, oral
antineoplastic agents
Drug-Related side effects and adverse reactions
imatinib
dasatinib
nilotinib
nilotinib
bosutinib
bosutinib
ponatinib
ponatinib
protein kinase inhibitors
ruxolitinib
ruxolitinib
janus kinases
information dissemination
continuity of patient care
hospital-physician relations
hospital-patient relations
physician-patient relations
drug interactions
pregnancy
protein-tyrosine kinases
Tyrosine Kinase Inhibitor
Dasatinib
Imatinib Mesylate
Tyrosine Kinase Inhibitors
nilotinib
ruxolitinib
pyrazoles
aniline compounds
nitriles
quinolines
imidazoles
pyridazines
---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/resume.md?type=text.html
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/article.md?type=text.html
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/1D/61/telecharger.md?code_langue=fr&format=application/pdf&titre=Version%20PDF
2006
France
French
antibodies, monoclonal
neoplasms
protein-tyrosine kinases
gastrointestinal stromal tumors
clinical trials as topic
antineoplastic agents
neoplastic processes
angiogenesis inhibitors
breast neoplasms
leukemia, myelogenous, chronic, bcr-abl positive
treatment outcome
Tyrosine Kinase Inhibitors
journal article
HER2 positive breast cancer
---